"Stryker concludes Inari Medical acquisition for $4.9bn" was originally created and published by Medical Device Network, a ...

Stryker Corp. yesterday closed on its $4.9 billion acquisition of Inari Medical Inc., which is now a wholly owned subsidiary ...

“The acquisition of Inari Medical marks a significant milestone in expanding our interventional endovascular portfolio,” said Kevin Lobo, Chair and Chief Executive Officer, Stryker. “We look forward ...

The Portage, Michigan–based orthopedic and surgical device giant announced last month that it struck a deal to acquire Inari ...

1. Stryker entered a definitive agreement to acquire medical device company Inari Medical for about $4.9 billion. 2. Stryker's net sales grew to $6.4 billion in the fourth quarter of 2024, and ...

Stryker reported $6.4 billion in sales and $22,595 million in operating profit for the quarter ending December 31, 2024, ...

A significant recent development was the announcement of Stryker's intent to acquire Inari Medical (TASE:PMCN) for $80 per share in cash, valuing the equity at $4.9 billion. This acquisition is ...

Stryker has completed the previously announced acquisition of Inari Medical for a total equity value of nearly $4.9bn, marking a significant expansion into the venous thromboembolism (VTE ...

Portage, Michigan, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical ...

Stryker (SYK) announced that it has completed the acquisition of Inari Medical (NARI), a company that provides innovative solutions for venous thromboembolism, or VTE, clot removal without the use ...